Hayat Pharmaceutical Industries Co (AMM:HPIC) Change In Receivables : JOD-1.55 Mil (TTM As of Mar. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Hayat Pharmaceutical Industries Co Change In Receivables?

Hayat Pharmaceutical Industries Co's change in receivables for the quarter that ended in Mar. 2025 was JOD-1.55 Mil. It means Hayat Pharmaceutical Industries Co's Accounts Receivable increased by JOD1.55 Mil from Dec. 2024 to Mar. 2025 .

Hayat Pharmaceutical Industries Co's change in receivables for the fiscal year that ended in Dec. 2024 was JOD-0.98 Mil. It means Hayat Pharmaceutical Industries Co's Accounts Receivable increased by JOD0.98 Mil from Dec. 2023 to Dec. 2024 .

Hayat Pharmaceutical Industries Co's Accounts Receivable for the quarter that ended in Mar. 2025 was JOD12.20 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hayat Pharmaceutical Industries Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 395.85.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hayat Pharmaceutical Industries Co's liquidation value for the three months ended in Mar. 2025 was JOD12.11 Mil.

Hayat Pharmaceutical Industries Co Change In Receivables Historical Data

The historical data trend for Hayat Pharmaceutical Industries Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hayat Pharmaceutical Industries Co Change In Receivables Chart

Hayat Pharmaceutical Industries Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-1.82

2.54

-1.91

-0.33

-0.98

Hayat Pharmaceutical Industries Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-1.10	-	-	-	-1.55

Hayat Pharmaceutical Industries Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD-1.55 Mil.

Hayat Pharmaceutical Industries Co (AMM:HPIC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hayat Pharmaceutical Industries Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	12.203	/	2.813	*	91
=	395.85

2. In Ben Graham's calculation of liquidation value, Hayat Pharmaceutical Industries Co's accounts receivable are only considered to be worth 75% of book value:

Hayat Pharmaceutical Industries Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	8.152	-	7.242	+	0.75 * 12.203	+	0.5 * 4.087
=	12.11

Hayat Pharmaceutical Industries Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hayat Pharmaceutical Industries Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Hayat Pharmaceutical Industries Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hayat Pharmaceutical Industries Co (AMM:HPIC) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

Nile St. Al-Rajeeb, P.O. Box 1564, Amman, JOR, 11118

Website

https://www.hayatpharma.com

Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. Its principal activity is producing human and veterinary in all its forms and medical stickers and stockings. The company is also involved in the production of medical supplies, body care lotions, cosmetics, and initiating marketing campaigns as well as import and export operations. It has developed and registered a hundred sixteen different dosage forms/pack sizes in the Jordan market representing fifty six different brands (molecules) in various therapeutic areas. Its products include Cardiovascular system, Infectious disease Dermatology, Gastrointestinal system, and Respiratory system.

Hayat Pharmaceutical Industries Co Headlines

No Headlines